Advocacy for cancer control is just beginning in LMCs, and has yet to take root in many. The history of cancer advocacy is very recent even in high-income countries, yet its impact has been great. Where the public has spoken out, governments and health care professionals have listened, at least in the United States and Europe. One should not underestimate the challenges of developing advocacy in LMCs, but the potential benefits in terms of more appropriate resources and attention to cancer make investing in advocacy very attractive. The global advocacy community has a role to play in assisting those in LMCs with information and strategies, while respecting the local political and social structures. As is the case with other aspects of cancer control, much of this work must take place person to person and country by country.

RECOMMENDATION 9-1. Established cancer advocacy organizations, mainly in high-income countries, should actively support and assist the growth of cancer advocacy in LMCs. Specific activities would include setting up advocacy networks within countries, within regions and internationally; identifying successful approaches to cancer advocacy and replicating or adapting them for use in other settings; and providing hands-on training and technical assistance.


American Cancer Society. 2006. American Cancer Society. [Online]. Available: [accessed July 3, 2006].

European Breast Cancer Coalition. 2006. Europa Donna. [Online]. Available: [accessed July 3, 2006].

Gray N. 2005. The Role of Advocacy in Cancer Control in Low- and Middle-Income Countries. Paper commissioned by the Institute of Medicine.

Gray N, Daube M. 1976. Guidelines for Smoking Control. Geneva, Switzerland: UICC.

International Union Against Cancer. 2006. Making a World of Difference. [Online]. Available: [accessed July 3, 2006].

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement